Updates from FDA

Headaches are a common complaint among patients of all ages, with women nearly twice as likely as men to have had a severe headache or migraine in the past 3 months.

Mary Warner

A high intake of dietary fiber is associated with extensive health benefits including lower cholesterol and a reduced risk of heart disease.

Mickie Cathers

While the market for new drugs that can treat diabetes has boomed, until recently there has been little news on the prevention front.

Lauren Howell, PharmD

Treatment for menopause symptoms continues to be a topic of great controversy among health care providers and menopausal patients themselves.

Sonya Collins

The first COVID-19 vaccines gained FDA EUA status in late 2020, but as new vaccines have emerged and some FDA EUAs have changed to approvals, health care personnel have had to stay up to date in an ever-changing environment.

Johanna Taylor Katroscik, PharmD

Since July 2022, pharmacists have been able to prescribe Paxlovid (Pfizer) with certain limitations.

Lauren Howell, PharmD

A November 2022 study published in the Journal of the American College of Cardiology spotlights the racial disparities in current cholesterol treatment guidelines that are based on studies overrepresenting white patients.

Clarissa Chan, PharmD

While there may not be a known cure for colds, we can at least reduce bothersome symptoms, improve our sense of well-being, and receive some relief.

A  November 2022 survey published in the Annals of Allergy, Asthma & Immunology of more than 1,000 adults with food allergies has helped shed light on the challenges patients face with epinephrine autoinjectors (EAIs).

Clarissa Chan, PharmD